Recruiting NA Cervical Cancer

New treatment option for Cervical Cancer

Official title Novel, One Stop, Affordable, Point of Care and AI Supported System of Screening, Triage and Treatment Selection for Cervical Cancer in LMICs

ClinicalTrials.gov ID: NCT06042543

What this study is testing

What it's testing
Artificial intelligence (AI) is fast gaining reputation as a highly promising solution for cervical cancer screening. AI-based detection of cervical neoplasias is named automated visual exam (AVE) by the National Cancer Institute, USA.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 25 to 49, women only

You may be able to join if

  • No cervical screening during the previous 3 years
  • Between the ages of 25 and 49 years
  • Understands and signs a written informed consent form

You likely can't join if

  • Refusal to take part for any reason
  • Actively menstruating or pregnant
  • Treated earlier for cervical precancer or cancer

The study team makes the final eligibility decision.

Where it's taking place

  • Cincinnati, Ohio, United States
  • Harare, Zimbabwe

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling female, 25 years to 49 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Cincinnati, Ohio, United States; Harare, Zimbabwe. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.